
The number of companies objecting to tokenization transactions on the New York Stock Exchange increased to 26, with the participation of IBM, Oracle, Intel and IonQ.
While IBM, Oracle, Intel and IonQ were added to the companies objecting to the tokenization of their shares in the USA, the total number of companies opposing the transactions within the New York Stock Exchange reached 26.
AI-generated summary
In September, the SEC allowed crypto companies to trade tokenized US shares through the 'Innovation Exemption' system.
The number of large companies objecting to the tokenization of their shares in the USA is increasing day by day. Finally, 4 new companies were added to this group. According to the information provided by the US media The Block, IBM, Oracle, Intel and IonQ objected to being traded in tokenized form within the New York Stock Exchange.
They did not give a reason
With these objections, the number of companies that do not want to be traded on the OKX-ICE platform, which was jointly established by ICE, the parent company of the New York Stock Exchange, has increased to 26. It is also noteworthy that most of the companies do not explain their reasons in their official objection notifications. Therefore, it is not clear whether these giant companies are really opposing tokenization or just the OKX-ICE platform.
SEC grants this permission
As it is known, the US Securities and Exchange Commission (SEC) launched a new system called "Innovation Exemption" in September. According to the system, crypto companies would be able to open tokenized US shares for trading on their platforms. There was no obligation to obtain approval from the companies holding shares for this transaction.
However, these companies were also given the right to object within 30 days. The number of companies making this objection has increased to 26 today. Among these companies, there are world giants such as Microsoft, Alphabet, Goldman Sachs, Coreweave, Wells Fargo and Moderna.
Fear of price change…
Although most companies do not explain the reason for their objection, it is known that one of the biggest reasons is the different prices expected to occur in different markets. For example, Microsoft stock closed at $400 on Nasdaq, while the tokenized version could drop to $390 over the weekend. However, since the main share will remain closed to transactions in the meantime, liquidity may shift to the tokenized side. Companies and traditional finance do not want this liquidity to deteriorate and are against this situation.
One of the biggest fears of companies is legal uncertainties and the possibility that some products may be created beyond their control.
AI outlook — possibilities, not facts
Increasing number of companies objecting to tokenization
Likely · Within days

Analyst Benjamin Cowen stated that it is critical for Bitcoin to close below $83,000 and warned that the rise to $87,000 could be a bull trap. Cowen drew attention to the downward trend after the US midterm elections.

QCP Capital stated that the $78,000 support is critical in the Bitcoin market, which is suppressed by geopolitical tensions and ETF outflows. The balance sheet announcements of technology giants Microsoft, Alphabet and Amazon are expected to determine the short-term direction of the market.

The US midterm elections will determine the legal framework that will regulate the cryptocurrency market and the future of controls for the sector. While Democrats winning the majority could increase scrutiny, the industry is heavily funding elections through Fairshake.

Arthur Hayes announced that he made a profit by transferring ETH, ENA, UNI and other altcoin assets worth $ 22.28 million to OTC platforms.

In their joint letter to the SEC, six major crypto organizations demanded that digital commodity status not only remain in comments but be guaranteed by being included in official and binding rules.

Glassnode analysts stated that $ 80 thousand is the support level for Bitcoin and $ 87 thousand 700 is the resistance level. US inflation and ETF outflows stand out as short-term risk factors.